XML 22 R13.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock Options
9 Months Ended
Mar. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Options

NOTE 6 – STOCK OPTIONS

 

Stock Options

 

A summary of stock options for the nine months ended March 31, 2018 is as follows:

 

    Number of   Weighted - Average
    Shares   Exercise Price
Outstanding at June 30, 2017     2,500,000     $ 0.08  
Granted     —         —    
Forfeited     —         —    
Outstanding at December 31, 2017     2,500,000     $ 0.08  
Exercisable at December 31, 2017     2,500,000     $ 0.08  

 

At March 31, 2018, the Company had 2,500,000 of options outstanding and exercisable. The options expire in February, 2020, and are exercisable at $0.08 per share. There were no options granted during the nine months ended March 31, 2018 and the Company recognized no stock-based compensation expense related to stock options during the three and nine months ended March 31, 2018 and 2017, respectively. As of March 31, 2018, there was no remaining unrecognized compensation costs related to stock options and no intrinsic value.

 

Additional information regarding options outstanding as of March 31, 2018 is as follows:

 

Options Outstanding at
March 31, 2018
  Options Exercisable at
March 31, 2018
                  Weighted                          
                  Average       Weighted               Weighted  
          Number of       Remaining       Average       Number of       Average  
  Range of        Shares       Contractual Life       Exercise       Shares       Exercise  
  Exercise       Outstanding       (Years)       Price       Exercisable       Price  
$ 0.08       2,500,000       1.92     $ 0.08       2,500,000     $ 0.08  
          2,500,000                       2,500,000